People · Operator
Named in public records as an officer, director or promoter · active 2007–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bamboo Therapeutics, Inc. | — | Biotechnology | Series C | $49.5M | $2.0B | 2016 |
| Nanocor Therapeutics Inc | — | Biotechnology | Series A | $6.3M | $225.9M | 2007 |
| Chatham Therapeutics Llc | — | Biotechnology | Pre-Seed | $201K | $11.1M | 2011 |
Richard Jude Samulski at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Jude Samulski on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sheila Mikhail | 1 | 2 |
| JADE JUDE SAMULSKI | 1 | 1 |
| SCOTT JUDE MCPHEE | 1 | 1 |
| Sheila Ann Mikhail | 1 | 1 |
| Gerald Laurence Klein | 1 | 1 |
| Robert Jude Smith | 1 | 1 |
| Michael Jude Goettler | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.